Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...

Having lupus may increase your risk of food allergies. And certain foods may trigger lupus flares. Learn more.

Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.

REPEAT kidney biopsies may play an essential role in managing lupus nephritis, particularly for patients whose disease ...

2 Key Laboratory of Immune Response and Immunotherapy, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China 3 University of Chinese Academy of Sciences, Beijing, ...

Kezar Life Sciences announced the termination of Phase 2b PALIZADE clinical trial of zetomipzomib, an investigational therapy ...

Lupus (systemic lupus erythematosus) and multiple sclerosis can appear similar in many ways. Both lupus and MS are chronic autoimmune diseases. More than 100 different autoimmune diseases exist, with ...

particularly due to lupus nephritis (LN). The standard therapeutic approach involving mycophenolate mofetil, cyclophosphamide, and glucocorticoids has shown limitations due to cumulative toxicity and ...

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the ...

Positive topline results were announced from a phase 3 study of obinutuzumab in patients with lupus nephritis. Obinutuzumab, a monoclonal antibody that targets the CD20 receptor on B-cells, is ...

Kezar was testing the treatment, zetomipzomib, in patients with active lupus nephritis, a type of kidney disease caused by lupus - where the body's immune system attacks its own cells and organs.